Proactiveinvestors Australia Johnson & Johnson https://www.proactiveinvestors.com.au Proactiveinvestors Australia Johnson & Johnson RSS feed en Wed, 29 Jan 2020 20:09:44 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Johnson & Johnson slapped with $8B verdict in lawsuit over antipsychotic drug Risperdal: Media Reports https://www.proactiveinvestors.com.au/companies/news/904486/johnson--johnson-slapped-with-8b-verdict-in-lawsuit-over-antipsychotic-drug-risperdal-media-reports-904486.html Wed, 09 Oct 2019 12:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/904486/johnson--johnson-slapped-with-8b-verdict-in-lawsuit-over-antipsychotic-drug-risperdal-media-reports-904486.html Johnson & Johnson third-quarter results beat estimates; raises guidance for 2018 https://www.proactiveinvestors.com.au/companies/news/207189/johnson-johnson-third-quarter-results-beat-estimates-raises-guidance-for-2018-207189.html Tue, 16 Oct 2018 13:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207189/johnson-johnson-third-quarter-results-beat-estimates-raises-guidance-for-2018-207189.html Johnson & Johnson ordered to pay US$4.7bn in damages to women in talc cancer case https://www.proactiveinvestors.com.au/companies/news/200765/johnson-johnson-ordered-to-pay-us47bn-in-damages-to-women-in-talc-cancer-case-200765.html Fri, 13 Jul 2018 11:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/200765/johnson-johnson-ordered-to-pay-us47bn-in-damages-to-women-in-talc-cancer-case-200765.html J&J hit with US$21.7mln verdict in second talcum powder-cancer trial https://www.proactiveinvestors.com.au/companies/news/197665/jj-hit-with-us217mln-verdict-in-second-talcum-powder-cancer-trial-197665.html Thu, 24 May 2018 16:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/197665/jj-hit-with-us217mln-verdict-in-second-talcum-powder-cancer-trial-197665.html Pharma sales turbocharge Johnson & Johnson’s first-quarter earnings beat https://www.proactiveinvestors.com.au/companies/news/195157/pharma-sales-turbocharge-johnson-johnsons-first-quarter-earnings-beat-195157.html Tue, 17 Apr 2018 12:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195157/pharma-sales-turbocharge-johnson-johnsons-first-quarter-earnings-beat-195157.html Johnson & Johnson, Imerys may face more suits related to baby powder, Reuters Says https://www.proactiveinvestors.com.au/companies/news/195059/johnson-johnson-imerys-may-face-more-suits-related-to-baby-powder-reuters-says-195059.html Mon, 16 Apr 2018 13:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195059/johnson-johnson-imerys-may-face-more-suits-related-to-baby-powder-reuters-says-195059.html Johnson & Johnson, Imerys ordered to pay additional US$80mln in punitive damages in talc-cancer case https://www.proactiveinvestors.com.au/companies/news/194789/johnson-johnson-imerys-ordered-to-pay-additional-us80mln-in-punitive-damages-in-talc-cancer-case-194789.html Wed, 11 Apr 2018 19:38:00 +1000 https://www.proactiveinvestors.com.au/companies/news/194789/johnson-johnson-imerys-ordered-to-pay-additional-us80mln-in-punitive-damages-in-talc-cancer-case-194789.html Johnson & Johnson, Imerys ordered by court to pay at least US$37mln in asbestos suit https://www.proactiveinvestors.com.au/companies/news/194458/johnson-johnson-imerys-ordered-by-court-to-pay-at-least-us37mln-in-asbestos-suit-194458.html Fri, 06 Apr 2018 19:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/194458/johnson-johnson-imerys-ordered-by-court-to-pay-at-least-us37mln-in-asbestos-suit-194458.html Johnson & Johnson receives US$2.1bn offer for LifeScan Inc. from Platinum Equity https://www.proactiveinvestors.com.au/companies/news/193316/johnson-johnson-receives-us21bn-offer-for-lifescan-inc-from-platinum-equity-193316.html Fri, 16 Mar 2018 14:08:00 +1100 https://www.proactiveinvestors.com.au/companies/news/193316/johnson-johnson-receives-us21bn-offer-for-lifescan-inc-from-platinum-equity-193316.html New tax law drags Johnson & Johnson’s fourth quarter into red territory but sales up https://www.proactiveinvestors.com.au/companies/news/190472/new-tax-law-drags-johnson-johnsons-fourth-quarter-into-red-territory-but-sales-up-190472.html Tue, 23 Jan 2018 13:19:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190472/new-tax-law-drags-johnson-johnsons-fourth-quarter-into-red-territory-but-sales-up-190472.html Johnson & Johnson, Chesapeake Energy, Verizon Communications and more - PRE-MARKET https://www.proactiveinvestors.com.au/companies/news/190471/johnson-johnson-chesapeake-energy-verizon-communications-and-more-pre-market-190471.html Tue, 23 Jan 2018 13:10:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190471/johnson-johnson-chesapeake-energy-verizon-communications-and-more-pre-market-190471.html Johnson & Johnson ups full year guidance after third quarter beats market expectations https://www.proactiveinvestors.com.au/companies/news/185723/johnson-johnson-ups-full-year-guidance-after-third-quarter-beats-market-expectations-185723.html Tue, 17 Oct 2017 12:17:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185723/johnson-johnson-ups-full-year-guidance-after-third-quarter-beats-market-expectations-185723.html Johnson & Johnson enjoys positive noises from analysts https://www.proactiveinvestors.com.au/companies/news/183325/johnson-johnson-enjoys-positive-noises-from-analysts-183325.html Fri, 01 Sep 2017 15:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183325/johnson-johnson-enjoys-positive-noises-from-analysts-183325.html Johnson & Johnson shares advance as second quarter beats market expectations https://www.proactiveinvestors.com.au/companies/news/181069/johnson-johnson-shares-advance-as-second-quarter-beats-market-expectations-181069.html Tue, 18 Jul 2017 12:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181069/johnson-johnson-shares-advance-as-second-quarter-beats-market-expectations-181069.html Johnson & Johnson may seek to set aside talc cancer judgements after Supreme Court ruling https://www.proactiveinvestors.com.au/companies/news/179631/johnson-johnson-may-seek-to-set-aside-talc-cancer-judgements-after-supreme-court-ruling-179631.html Wed, 21 Jun 2017 13:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179631/johnson-johnson-may-seek-to-set-aside-talc-cancer-judgements-after-supreme-court-ruling-179631.html J&J, world's largest healthcare firm, agrees US$30bn deal to buy Actelion, Europe’s biggest biotech group https://www.proactiveinvestors.com.au/companies/news/172223/jj-world-s-largest-healthcare-firm-agrees-us30bn-deal-to-buy-actelion-europes-biggest-biotech-group-172223.html Thu, 26 Jan 2017 09:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/172223/jj-world-s-largest-healthcare-firm-agrees-us30bn-deal-to-buy-actelion-europes-biggest-biotech-group-172223.html Volte face: Johnson & Johnson re-enters acquisition talks with Swiss biotech firm Actelion https://www.proactiveinvestors.com.au/companies/news/170870/volte-face-johnson-johnson-re-enters-acquisition-talks-with-swiss-biotech-firm-actelion-170870.html Thu, 22 Dec 2016 13:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/170870/volte-face-johnson-johnson-re-enters-acquisition-talks-with-swiss-biotech-firm-actelion-170870.html Johnson & Johnson shares up despite $1bn penalty over hip implants https://www.proactiveinvestors.com.au/companies/news/169908/johnson-johnson-shares-up-despite-1bn-penalty-over-hip-implants-169908.html Fri, 02 Dec 2016 16:56:00 +1100 https://www.proactiveinvestors.com.au/companies/news/169908/johnson-johnson-shares-up-despite-1bn-penalty-over-hip-implants-169908.html Pfizer’s spoiler on Johnson & Johnson’s earnings rally https://www.proactiveinvestors.com.au/companies/news/167594/pfizers-spoiler-on-johnson-johnsons-earnings-rally-167594.html Tue, 18 Oct 2016 20:02:00 +1100 https://www.proactiveinvestors.com.au/companies/news/167594/pfizers-spoiler-on-johnson-johnsons-earnings-rally-167594.html J&J advances after results beat expectations https://www.proactiveinvestors.com.au/companies/news/128359/jj-advances-after-results-beat-expectations-128359.html Tue, 19 Jul 2016 13:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/128359/jj-advances-after-results-beat-expectations-128359.html Johnson & Johnson Q1 earnings bode well for Medtech season https://www.proactiveinvestors.com.au/companies/news/124995/johnson-johnson-q1-earnings-bode-well-for-medtech-season-124995.html Tue, 19 Apr 2016 20:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/124995/johnson-johnson-q1-earnings-bode-well-for-medtech-season-124995.html J&J shares seesaw on mixed results https://www.proactiveinvestors.com.au/companies/news/116161/jj-shares-seesaw-on-mixed-results-116161.html Tue, 13 Oct 2015 11:31:00 +1100 https://www.proactiveinvestors.com.au/companies/news/116161/jj-shares-seesaw-on-mixed-results-116161.html J&J to seek regulatory approval for 10 new drugs by 2019 that may generate over $1 bln revenue https://www.proactiveinvestors.com.au/companies/news/107050/jj-to-seek-regulatory-approval-for-10-new-drugs-by-2019-that-may-generate-over-1-bln-revenue-107050.html Wed, 20 May 2015 14:06:00 +1000 https://www.proactiveinvestors.com.au/companies/news/107050/jj-to-seek-regulatory-approval-for-10-new-drugs-by-2019-that-may-generate-over-1-bln-revenue-107050.html Johnson & Johnson hits 4-week low even as Q2 profit jumps better-than-expected 13% https://www.proactiveinvestors.com.au/companies/news/102298/johnson-johnson-hits-4-week-low-even-as-q2-profit-jumps-better-than-expected-13-55438.html Tue, 15 Jul 2014 14:18:00 +1000 https://www.proactiveinvestors.com.au/companies/news/102298/johnson-johnson-hits-4-week-low-even-as-q2-profit-jumps-better-than-expected-13-55438.html J&J hits one-week high as Q1 earnings beat, 2014 forecast boosted https://www.proactiveinvestors.com.au/companies/news/100847/jj-hits-one-week-high-as-q1-earnings-beat-2014-forecast-boosted-53453.html Tue, 15 Apr 2014 19:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/100847/jj-hits-one-week-high-as-q1-earnings-beat-2014-forecast-boosted-53453.html J&J Q4 net climbs 37% on strong drug sales https://www.proactiveinvestors.com.au/companies/news/99496/jj-q4-net-climbs-37-on-strong-drug-sales-51426.html Tue, 21 Jan 2014 13:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/99496/jj-q4-net-climbs-37-on-strong-drug-sales-51426.html J&J climbs to 2-month high as Q3 net beats on solid drug sales https://www.proactiveinvestors.com.au/companies/news/97892/jj-climbs-to-2-month-high-as-q3-net-beats-on-solid-drug-sales-48918.html Tue, 15 Oct 2013 13:52:00 +1100 https://www.proactiveinvestors.com.au/companies/news/97892/jj-climbs-to-2-month-high-as-q3-net-beats-on-solid-drug-sales-48918.html US shares under pressure amid mixed earnings reports https://www.proactiveinvestors.com.au/companies/news/96261/us-shares-under-pressure-amid-mixed-earnings-reports-46115.html Tue, 16 Jul 2013 14:36:00 +1000 https://www.proactiveinvestors.com.au/companies/news/96261/us-shares-under-pressure-amid-mixed-earnings-reports-46115.html J&J doubles profit, raises full-year guidance https://www.proactiveinvestors.com.au/companies/news/96262/jj-doubles-profit-raises-full-year-guidance-46112.html Tue, 16 Jul 2013 13:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/96262/jj-doubles-profit-raises-full-year-guidance-46112.html Johnson & Johnson acquires Aragon for up to $1 bln https://www.proactiveinvestors.com.au/companies/news/95655/johnson-johnson-acquires-aragon-for-up-to-1-bln-45069.html Mon, 17 Jun 2013 14:49:00 +1000 https://www.proactiveinvestors.com.au/companies/news/95655/johnson-johnson-acquires-aragon-for-up-to-1-bln-45069.html Johnson & Johnson profit beats the Street on higher drug sales https://www.proactiveinvestors.com.au/companies/news/94314/johnson-johnson-profit-beats-the-street-on-higher-drug-sales--42774.html Tue, 16 Apr 2013 13:53:00 +1000 https://www.proactiveinvestors.com.au/companies/news/94314/johnson-johnson-profit-beats-the-street-on-higher-drug-sales--42774.html Johnson & Johnson Q4 profit tops, revenue misses https://www.proactiveinvestors.com.au/companies/news/92543/johnson-johnson-q4-profit-tops-revenue-misses-39674.html Tue, 22 Jan 2013 13:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/92543/johnson-johnson-q4-profit-tops-revenue-misses-39674.html Johnson & Johnson Q3 earnings fall, raises full-year outlook https://www.proactiveinvestors.com.au/companies/news/90420/johnson-johnson-q3-earnings-fall-raises-full-year-outlook-36036.html Tue, 16 Oct 2012 14:29:00 +1100 https://www.proactiveinvestors.com.au/companies/news/90420/johnson-johnson-q3-earnings-fall-raises-full-year-outlook-36036.html Johnson & Johnson Q2 profit down 49%, shares down https://www.proactiveinvestors.com.au/companies/news/87941/johnson-johnson-q2-profit-down-49-shares-down-32059.html Tue, 17 Jul 2012 13:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/87941/johnson-johnson-q2-profit-down-49-shares-down-32059.html Johnson & Johnson says new use for blood clot drug Xarelto rejected by FDA https://www.proactiveinvestors.com.au/companies/news/87282/johnson-johnson-says-new-use-for-blood-clot-drug-xarelto-rejected-by-fda-30902.html Fri, 22 Jun 2012 13:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/87282/johnson-johnson-says-new-use-for-blood-clot-drug-xarelto-rejected-by-fda-30902.html Johnson & Johnson gets US regulator’s nod for Synthes acquisition https://www.proactiveinvestors.com.au/companies/news/86992/johnson-johnson-gets-us-regulators-nod-for-synthes-acquisition-30443.html Wed, 13 Jun 2012 13:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/86992/johnson-johnson-gets-us-regulators-nod-for-synthes-acquisition-30443.html Johnson & Johnson Q1 profit beats the street, sales decline 2.4% https://www.proactiveinvestors.com.au/companies/news/85407/johnson-johnson-q1-profit-beats-the-street-sales-decline-24-27830.html Tue, 17 Apr 2012 14:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/85407/johnson-johnson-q1-profit-beats-the-street-sales-decline-24-27830.html Johnson & Johnson Q4 profit sinks on hefty charges, but adjusted tops views https://www.proactiveinvestors.com.au/companies/news/83068/johnson-johnson-q4-profit-sinks-on-hefty-charges-but-adjusted-tops-views-23920.html Tue, 24 Jan 2012 13:58:00 +1100 https://www.proactiveinvestors.com.au/companies/news/83068/johnson-johnson-q4-profit-sinks-on-hefty-charges-but-adjusted-tops-views-23920.html Johnson & Johnson Q3 earnings fall on market adjustment for Synthes acquisition https://www.proactiveinvestors.com.au/companies/news/80649/-johnson-johnson-q3-earnings-fall-on-market-adjustment-for-synthes-acquisition-19810.html Tue, 18 Oct 2011 14:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/80649/-johnson-johnson-q3-earnings-fall-on-market-adjustment-for-synthes-acquisition-19810.html Johnson & Johnson tops Street despite 20% Q2 profit drop on pain-killer recalls https://www.proactiveinvestors.com.au/companies/news/78704/johnson-johnson-tops-street-despite-20-q2-profit-drop-on-pain-killer-recalls-16436.html Tue, 19 Jul 2011 15:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/78704/johnson-johnson-tops-street-despite-20-q2-profit-drop-on-pain-killer-recalls-16436.html US arthroscopy market to double by 2017, Stryker, Smith & Nephew, Johnson & Johnson to benefit https://www.proactiveinvestors.com.au/companies/news/78329/us-arthroscopy-market-to-double-by-2017-stryker-smith-nephew-johnson-johnson-to-benefit-15823.html Tue, 28 Jun 2011 14:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/78329/us-arthroscopy-market-to-double-by-2017-stryker-smith-nephew-johnson-johnson-to-benefit-15823.html Johnson & Johnson to buy Swiss medical device maker Synthes for $21.3bn https://www.proactiveinvestors.com.au/companies/news/77301/johnson-johnson-to-buy-swiss-medical-device-maker-synthes-for-213bn-14104.html Wed, 27 Apr 2011 13:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/77301/johnson-johnson-to-buy-swiss-medical-device-maker-synthes-for-213bn-14104.html Johnson & Johnson beats Q1 analyst estimates https://www.proactiveinvestors.com.au/companies/news/77227/johnson-johnson-beats-q1-analyst-estimates-13966.html Tue, 19 Apr 2011 19:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/77227/johnson-johnson-beats-q1-analyst-estimates-13966.html